Quantum computing company Quantinuum made a strong public debut on the Nasdaq on June 4, 2026, with shares opening at $68, a 13.3% jump from its initial public offering price of $60. The company raised $1.68 billion by selling 28 million shares, exceeding its initial marketing range of $53–$55. At the opening price, Quantinuum’s market capitalization reached approximately $17.63 billion.
Formed in 2021 through the merger of Honeywell’s quantum computing division and Cambridge Quantum, Quantinuum opted for a traditional IPO rather than a SPAC merger. CEO Rajeeb Hazra emphasized the move was intended to build credibility and demonstrate alignment between company claims and achievements. The offering was managed by J.P. Morgan, Morgan Stanley, and other major underwriters.
Quantinuum’s full-stack quantum platform serves clients in pharmaceuticals, finance, government, and industrial sectors, including JPMorgan Chase and Amgen. Despite the successful listing, the company faces financial challenges: first-quarter revenue fell 73% year-over-year to $5.24 million, and net losses widened to $136.5 million. Honeywell retains a majority stake and remains a strategic partner.
The IPO follows growing investor interest in quantum computing, rival IonQ’s stock having risen 52% this year to a $25.47 billion market cap. Quantinuum also recently signed a non-binding MOU with Mitsubishi Electric and a letter of intent with the U.S. Department of Commerce for federal funding under the CHIPS Act, highlighting government support for the sector.
